[ad_1]
LONDON (Reuters) – New hope could see the light of day in 2030 by eliminating the hepatitis B and C viruses that infect 325 million people worldwide and kill more than 1.3 million people every year. reported Monday a French newspaper.
According to the newspaper Le Monde, a study by the World Health Organization (WHO) indicates that screening and treatment programs worth $ 6 billion could help achieve this goal , stating that this would reduce new infections by 90% and deaths by 65% within 10 years.
The study, published in Lancet Global Health on July 25, just before World Hepatitis Day on July 28, found that B and C were the five most common types of hepatitis. "A.B.C.E" (A, B, C, D and E), responsible for 95% of deaths, mainly due to cirrhosis of the liver or liver cancer occurring in the patient with chronic hepatitis.
The World Health Organization (WHO) adopted in 2016 a resolution to reduce by 90% injuries and deaths by 65% by 2030, thanks to several interventions, such as Hepatitis B vaccination, prevention and risk reduction programs, screening and treatment of both types of hepatitis.
| Hepatitis C Screening Programs Are Effective, Achievable And Affordable (Pixabee) |
Complete health coverage
Le Monde also pointed out that David Tordrup, of the University of Utrecht in the Netherlands, and his colleagues at the World Health Organization, had designed the cost of this component in a publication of the The Lancet Global Health magazine, and that it encompbaded 67 low-income and middle-income countries, where the vast majority of patients with hepatitis B & C) "PE, C" 90% in the first group and 73% per second.
The experts tested three scenarios: the first is to follow the current approach, the second to apply the WHO recommendations regarding testing and antiretroviral therapy, and the third is ambitious and aims to eradicate the disease. from here 2030.Achieving this goal would require an additional $ 58.7 billion over this period, or $ 6 billion a year, according to researchers, which could prevent 4.5 million premature deaths over the next 10 years.
In a statement, WHO Director-General Tidros Adhanom Grepress said that 80% of people with hepatitis had no access to prevention, detection and treatment of these diseases, and called for a mobilization on the subject.
Some, like India, have announced a free trial and treatment of hepatitis B and C as part of a comprehensive health coverage system, facilitated by the low price of antiviral drugs. , Where a one-year treatment in India costs only $ 30 for B and $ 40 for C, while the price of a 12-week course in France ranges from 25,000 to 37,000.
Ivan Heutin, of the World Health Organization's Hepatitis Program and author of the second Lancet Global Health article, said that programs for the examination of hepatitis and hepatitis effective, feasible and affordable, have a significant impact and thus meet all the requirements to be included in comprehensive health coverage systems.
Source link
